Retatrutide carries an additional layer of complexity: it is still an investigational compound
Li C, Luo J, Jiang M, Wang K (2022) The efficacy and safety of the combination therapy with GLP-1 receptor agonists and SGLT-2 inhibitors in type 2 diabetes mellitus: a systematic review and meta-analysis
They may contain incorrect doses, different ingredients (like unstudied salt forms), contaminants, or no active drug at all
Final Thought The rise in supplement scams like BuildLeaf Tirzepatide GLP-1 Herbal Oral Liquid shows how important it is to question health products sold online
Retatrutide Deep Dive: The Triple Agonist Understanding Retatrutide requires appreciating what makes it fundamentally different from earlier weight loss medications
Aim for 8,000 to 10,000 steps daily as a baseline